Study Examines Benefits, Risks to Cognitive Function of HRT for Women Ages 50 to 55 Years Postmenopausal hormone therapy with conjugated equine estrogens (CEEs) was not associated with overall sustained benefit or risk to cognitive function when given to women ages 50 to 55 years, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
June 24, 2013 - Newswise
Kevin Connolly in NPIcenter (press release) As the mission of Jarrow Formulas is to incorporate high quality, scientifically documented ingredients into each of our formulations, we have chosen Lipid Nutrition's Clarinol CLA as our new source for conjugated linolenic acid,says Kevin...